
Open‑Loop Health, a startup powering tele‑health companies, announced the acquisition of food‑as‑medicine startup Season Health. The terms of the transaction were not disclosed.

Vancouver-based biotech startup Aspect Biosystems announced it has received $58 million in funding from the Government of Canada to advance its diabetes cell therapy platform. The grant aims to keep the breakthrough development in Canada and accelerate clinical progress, supporting...

Penn Medicine Lancaster General Health has acquired the remaining ownership stake in the MRI Group and PET Partnership, previously co‑owned with Lancaster Radiology Associates. The deal, announced on April 2, gives Penn Medicine sole control of six imaging centers in Lancaster...

LatentView Analytics, an AI-driven analytics and consulting firm, completed a $3 million investment in Healtheon AI, a provider of AI agents for healthcare revenue cycle management. The funding will support Healtheon AI’s solutions for medical coding, claims processing and denial remediation,...

Japanese pharmaceutical company Shionogi announced a $2 billion agreement to acquire the rights to Radicava, a treatment for amyotrophic lateral sclerosis (ALS). The acquisition expands Shionogi's neurology portfolio and gives it greater control over commercialization and lifecycle management of the therapy....
Hospice News’ parent company WTWH Media announced the acquisition of HealthLeaders, a media and events platform for hospital and health‑system executives. The deal expands WTWH’s healthcare portfolio and enhances its ability to connect decision‑makers across the care continuum.
SV Health Investors, a private healthcare investment firm, announced the acquisition of EpiVax, a bioanalytical CRO specializing in immunogenicity risk assessment for pharma and biotech companies. The deal, announced on April 2, 2026, adds a new platform investment to SVHI’s...
Community Health Systems completed the sale of its Huntsville, Alabama hospital, Crestwood Medical Center, to nonprofit Huntsville Hospital Health System for $459 million. The purchase price exceeds the $450 million initially proposed, reflecting a post‑closing working‑capital adjustment. The deal furthers...

Premier Radiology Services, backed by Grovecourt Capital Partners, announced it will acquire Global Imaging Solutions (GLOBIS), a teleradiology group operating in 28 states with 25 subspecialized radiologists. The terms of the deal were undisclosed, but the acquisition expands Premier’s network...
Cambridge‑based biotech Zag Bio announced an $80 million Series A financing to move its bispecific antibody platform targeting central tolerance into the clinic. The funding will support development of its lead program aimed at treating autoimmune diseases by rewiring the thymus. The...

CareTrust REIT announced it has closed two new investments totaling $119 million, acquiring a portfolio of five skilled nursing facilities in the Midwest and a senior housing and skilled nursing campus in Southern California. Both assets are financed via mortgage loans...

Weight‑loss app Noom announced the acquisition of 503A pharmacy Tailor Made Compounding, a compounding pharmacy focused on aging, hormone‑replacement and peptide therapies. The deal will enable Noom to broaden its behavior‑change programs into healthy‑aging and prescription‑grade wellness, with Tailor Made...
Peachy, a Botox provider with 15 locations, announced it has secured a new investment from Stride Consumer Partners. Although the terms were undisclosed, the funding will support nationwide expansion and growth into male consumers. The deal adds to Peachy's existing...

BrightSpring Health Services completed the sale of its ResCare Community Living business to Sevita for $835 million in cash. The divestiture, delayed by antitrust concerns, closed on March 31, 2026, allowing both companies to focus on their strategic priorities.

Atavistik Bio announced the completion of its Series B financing, raising a total of $160 million, with $120 million closed in December 2025 and a $40 million extension in March 2026. The capital will fund the development of its allosteric...

Eli Lilly announced an agreement to acquire Centessa Pharmaceuticals, a developer of experimental narcolepsy treatments, for approximately $6.3 billion in cash. The deal, reported on March 31 2026, expands Lilly’s sleep‑disorder pipeline and brings Centessa’s Phase 2 drug candidates into its portfolio. Centessa, founded...
Tempest Therapeutics announced the completion of its strategic acquisition of a portfolio of dual‑targeting CAR‑T assets from Factor Bioscience Inc. The all‑stock transaction adds next‑generation CAR‑T candidates, including TPST‑2003, to Tempest’s pipeline. Financial terms were not disclosed.

Kain Capital has made an investment in White Wilson Medical Center, marking a new capital infusion for the healthcare provider. The deal, details undisclosed, was announced concurrently with the appointment of Brad Logan as CEO.
Kyntra Bio announced the completion of the sale of its FibroGen China assets to AstraZeneca, enabling full repayment of its senior secured term loan and extending its cash runway into 2028.
Agilent Technologies completed the acquisition of Biocare Medical, a cancer diagnostics firm, for nearly $1 billion. The deal adds a high‑margin diagnostics business to Agilent’s portfolio, expanding its recurring revenue streams. The acquisition was reported on March 29 2026 as a recent transaction.

On March 29, Eli Lilly announced a $2.75 billion corporate investment in Insilico Medicine, paying $115 million upfront and tying the remaining $2.63 billion to milestones and royalties. The deal grants Lilly global rights to develop and commercialize oral therapeutics discovered by Insilico’s AI...

Thesis Care, previously known as Trovo Health, secured $45 million in a Series A round led by Oak HC/FT, with participation from CRV and Black Opal Ventures. The funding brings the company's total capital to $60 million and will support...

LDC, the private equity arm of Lloyds Banking Group, has completed its exit of PAM Healthcare by selling the occupational health business to Optima Healthcare. The acquisition expands Optima Healthcare’s footprint in the occupational health sector. Deal terms were not...

Health Management Associates (HMA), a national health and human services consulting firm, announced the acquisition of HealthTech Solutions, a Medicaid-focused technology and analytics provider. The deal, terms undisclosed, will allow HMA to offer end‑to‑end services for state Medicaid agencies, from...
Trinity Capital Inc., an international alternative asset manager, has committed $50 million in growth capital to Sage Health, a primary‑care and wellness provider for Medicare‑eligible seniors. The funding will support Sage Health's expansion of neighborhood health centers in underserved areas,...
Florida State University will acquire Tallahassee Memorial HealthCare from the City of Tallahassee, paying $109 million over 30 years and committing $1.7 billion in local investments. The transaction was approved by the university’s board of trustees, the Florida Board of Governors, and city...

U.K.-based Vitality announced the acquisition of Ramp Health, a provider of risk and safety mitigation services for healthcare. The deal merges Vitality's behavioral change platform with Ramp Health's AI-driven workplace safety and on‑site clinical services, aiming to deliver integrated health...

Swedish biotech company VERIGRAFT announced it has raised $10 million from existing investors to fund the initiation of a pivotal Phase II/III trial of its personalized tissue‑engineered vein (P‑TEV) for chronic venous insufficiency. The financing will support trial sites in...
Centurion Foundation announced that Roger Williams Memorial Center and Our Lady of Fatima Hospital have been financially stabilized through a recapitalization package of over $100 million in privately financed bonds and an $18 million state reserve fund, and are now overseen by the new nonprofit CharterCARE Health of Rhode...
Infosys announced it will acquire digital transformation firm Optimum Healthcare IT for up to $465 million from private equity owner Achieve Partners. The deal will expand Infosys' health IT footprint and is expected to close in Q1 2027 pending regulatory...

Digital mental health platform Cerebral announced the acquisition of Inflow, a behavioral health app for ADHD, to broaden its continuous care offerings. The deal will keep both platforms operating separately while integrating Inflow’s digital therapeutic tools with Cerebral’s telehealth services....
U.K.-based biotech Immutrin raised $87 million in a Series A round led by Frazier Life Sciences, with participation from Qiming Venture Partners, F‑Prime, SR One, Cambridge Enterprise Ventures and Cambridge Innovation Capital. The capital will fund the development of its lead antibody...
UK digital health startup JAAQ announced a £13 million ($16.5 million) Series A round led by Meridian Health Ventures, Fuel Ventures, Bolt Angels and Guinness Ventures. The funding will accelerate enterprise partnerships, expand into US markets and scale its AI-native...
London-based AI and patient data platform Sanius Health has completed the acquisition of Cambridge digital health company THERAPYAUDIT for an undisclosed cash consideration. The deal expands Sanius's AI infrastructure to over 35 NHS hospitals, enhancing therapy monitoring and predictive analytics...

Palm Primary Care, part of MBF Healthcare Partners II portfolio, has completed the acquisition of two primary care clinics in Azle, Texas from Texas Health Physicians Group, expanding its footprint to nine clinics in Tarrant and Dallas Counties. The clinics...

Triangle Health announced a $4 million fundraising round to develop its AI platform that helps users upload health records and receive treatment suggestions. The funding will support product development and scaling of its AI-driven health insights service.

Somerset Indus Capital Partners announced the closing of its third fund, Fund III, raising $288 million, surpassing its $250 million target. The fund will focus on healthcare investments in India's Tier II and Tier III markets, with typical investments of $15‑$40 million per company. The capital...

Cencora, Inc. announced it has signed a definitive agreement to acquire the retina business of EyeSouth Partners for $1.1 billion. The acquisition will integrate EyeSouth’s retina physicians into Cencora’s Retina Consultants of America network and is expected to be slightly accretive...

Apollo Hospitals Enterprise Limited (AHEL) completed the acquisition of a 99.42% stake in Apollo Health and Lifestyle Limited (AHLL) for INR 12.54 crore, after securing Competition Commission of India approval on Jan 20, 2026. The deal raises AHEL's ownership to...
Harris Health Alliance (HHA) has completed the acquisition of eRedbook, a leading digital parent‑held child health record, from Heathersoft. The deal adds the eRedbook platform, technology and customer base to HHA’s portfolio, enhancing its digital health offering across the NHS....
Abbott announced it will close its $21 billion acquisition of cancer‑test maker Exact Sciences on Monday, after receiving all required regulatory clearances. The deal, first announced in November 2025, adds Exact’s Cologuard and other early‑detection tests to Abbott’s diagnostics portfolio, boosting...

Sanofi announced a $180 million investment in California-based T-cell engager startup Kali, part of a larger deal valued at $1 billion. The funding will support Kali's development of next-generation T-cell therapies and marks Sanofi's renewed focus on the T-cell engager...
Imbiologics Corp., a biotech focused on antibody drugs for autoimmune diseases, debuted on the KOSDAQ on March 20, 2026, achieving a market capitalization of ₩1.5 trillion (≈$1.02 billion). The listing marks the company's entry into the public market and positions it as...
GE HealthCare has completed its acquisition of imaging software provider Intelerad for a base price of $2.3 billion. The deal expands GE’s cloud‑enabled, AI‑powered imaging platform, aiming to simplify radiology workflows and boost recurring revenue. Intelerad’s CEO Jordan Bazinsky said the...

In‑home care technology company MedArrive announced it has acquired assets from the now‑closed hospital‑at‑home provider Inbound Health. The acquisition enhances MedArrive’s AI‑backed patient navigation capabilities and expands its presence in the hospital‑at‑home market. The deal was disclosed on March 19,...
Chartis, a consulting and advisory firm, announced the acquisition of Leap AI, a generative AI vendor for operating‑room workflows. The deal integrates Leap AI’s technology into Chartis’ new AI studio, aiming to deliver AI‑driven solutions that improve healthcare operations and...
Atrium Therapeutics, a spin‑out from Novartis‑owned Avidity Biosciences, has launched as an independent, publicly traded company focused on RNA therapeutics for rare genetic cardiomyopathies. The company secured $270 million in funding and entered a licensing agreement with Novartis for its RNA‑targeting...

Health Universe, an AI-enabled healthcare workflow platform, announced a $6 million seed funding round led by Kleiner Perkins, bringing its total capital raised to $9.5 million. The funding will be used to expand marketing, sales, integrations, hiring, and accelerate adoption...

Aveanna Healthcare Holdings announced a $175.5 million acquisition of Family First Homecare, expanding its pediatric in‑home care footprint across multiple states. The deal, funded with cash and short‑term credit, is expected to close in Q2 2026, adding 27 locations and enhancing Aveanna’s...

Lantern, a specialty care platform serving over 12 million members, announced a $30 million growth investment led by Morgan Health and Echo Health Ventures. The funding will support expansion across employers and health plans, enhancing its network-of-excellence model and AI-enabled...